Empirical Anti-MRSA vs Standard Antibiotic Therapy and Risk of 30-Day Mortality in Patients Hospitalized for Pneumonia

IMPORTANCE: Use of empirical broad-spectrum antibiotics for pneumonia has increased owing to concern for resistant organisms, including methicillin-resistant Staphylococcus aureus (MRSA). The association of empirical anti-MRSA therapy with outcomes among patients with pneumonia is unknown, even for...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Intern Med
Main Authors: Jones, Barbara Ellen, Ying, Jian, Stevens, Vanessa, Haroldsen, Candace, He, Tao, Nevers, McKenna, Christensen, Matthew A., Nelson, Richard E., Stoddard, Gregory J., Sauer, Brian C., Yarbrough, Peter M., Jones, Makoto M., Goetz, Matthew Bidwell, Greene, Tom, Samore, Matthew H.
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2020
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7042818/
https://ncbi.nlm.nih.gov/pubmed/32065604
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2019.7495
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados